Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684801 · ClinicalTrials.gov registry record
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 605
- Enrollment target
NCT00684801: Completed study, sponsored by Case Comprehensive Cancer Center.
NCT00684801 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 605 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00684801 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 605 participants
- Enrollment target
Study Summary
RATIONALE: A disease management program may be more effective than standard therapy in improving quality of life and controlling symptoms in patients with cancer. PURPOSE: This clinical trial is studying a disease management program to see how well it works compared with usual care in patients with stage III or stage IV lung cancer, stage III or stage IV pancreatic cancer, stage III or stage IV ovarian cancer, or stage III or stage IV colorectal cancer, and their caregivers.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-12 |
What the finished NCT00684801 record still lists
NCT00684801 is an observational study that tracks outcomes without assigning an intervention. The registered 605 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which questionnaire administration is the first listed.
NCT00684801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00684801 about?
NCT00684801 is a clinical study titled "Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers". RATIONALE: A disease management program may be more effective than standard therapy in improving quality of life and controlling symptoms in patients with cancer. PURPOSE: This clinical trial is studying a disease management program to see how well it works compared with usual care in patients with...
What is the current status of trial NCT00684801?
This trial is currently completed. The enrollment target is 605 participants. The study started on 2007-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00684801?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00684801?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia